z-logo
open-access-imgOpen Access
Analysis of Lymphocyte Subpopulations and Cytokines in COVID-19-Associated Pneumonia and Community-Acquired Pneumonia
Author(s) -
Guohong Liu,
Xianghu Jiang,
Xiaojiao Zeng,
Yunbao Pan,
Haibo Xu
Publication year - 2021
Publication title -
journal of immunology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.315
H-Index - 83
eISSN - 2314-8861
pISSN - 2314-7156
DOI - 10.1155/2021/6657894
Subject(s) - pneumonia , covid-19 , immunology , community acquired pneumonia , medicine , lymphocyte , virology , pathology , infectious disease (medical specialty) , outbreak , disease
Background The 2019 novel coronavirus SARS-CoV-2 caused large outbreaks of COVID-19 worldwide. COVID-19 resembles community-acquired pneumonia (CAP). Our aim was to identify lymphocyte subpopulations to distinguish between COVID-19 and CAP.Methods We compared the peripheral blood lymphocytes and their subsets in 296 patients with COVID-19 and 130 patients with CAP. Parameters for independent prediction of COVID-19 were calculated by logistic regression.Results The main lymphocyte subpopulations (CD3 + CD4 + , CD16 + CD56 + , and CD4 + /CD8 + ratio) and cytokines (TNF- α and IFN- γ ) of COVID-19 patients were significantly different from that of CAP patients. CD16 + CD56 + %, CD4 + /CD8 + ratio, CD19 + , and CD3 + CD4 + were identified as predictors of COVID-19 diagnosis by logistic regression. In addition, the CD3 + CD4 + counts, CD3 + CD8 + counts, andTNF- α are independent predictors of disease severity in patients.Conclusions Lymphopenia is an important part of SARS-CoV-2 infection, and lymphocyte subsets and cytokines may be useful to predict the severity and clinical outcomes of the disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom